High Arctic Energy Services Inc
HGHAF
$0.77
-$0.0094-1.21%
| Weiss Ratings | HGHAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | C- | |||
| Rating Factors | HGHAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Good | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | HGHAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.44 | |||
| Price History | HGHAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.21% | |||
| 30-Day Total Return | -2.53% | |||
| 60-Day Total Return | -4.94% | |||
| 90-Day Total Return | -6.05% | |||
| Year to Date Total Return | -1.28% | |||
| 1-Year Total Return | -21.54% | |||
| 2-Year Total Return | -38.81% | |||
| 3-Year Total Return | -47.06% | |||
| 5-Year Total Return | 31.28% | |||
| 52-Week High % Change | -84.22% | |||
| 52-Week Low % Change | 26.21% | |||
| Price | HGHAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $4.88 | |||
| 52-Week Low Price | $0.61 | |||
| 52-Week Low Price (Date) | Oct 25, 2024 | |||
| 52-Week High Price (Date) | Jun 21, 2024 | |||
| Valuation | HGHAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 9.12M | |||
| Enterprise Value | 9.58M | |||
| Price/Earnings (TTM) | 0.41 | |||
| Earnings Per Share (TTM) | 1.86 | |||
| Earnings Per Share Growth | -225.65% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.50 | |||
| Price/Book (Q) | 0.56 | |||
| Enterprise Value/Revenue (TTM) | 0.50 | |||
| Price | $0.77 | |||
| Enterprise Value/EBITDA (TTM) | 5.06 | |||
| Enterprise Value/EBIT | -21.68 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | HGHAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 12.45M | |||
| Dividend Yield | 1.91% | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | $0.01 | |||
| Payout Ratio (TTM) | 0.00% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | HGHAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 403 508 7836 | |||
| Address | 330 – 5th Avenue SW Calgary, AB T2P 0L4 | |||
| Website | www.haes.ca | |||
| Country | Canada | |||
| Year Founded | 1993 | |||
| Profitability | HGHAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -2.30% | |||
| Profit Margin | 121.41% | |||
| Management Effectiveness | HGHAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -0.50% | |||
| Return on Equity | 2.24% | |||
| Income Statement | HGHAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 19.22M | |||
| Total Revenue (TTM) | 19.22M | |||
| Revenue Per Share | $1.54 | |||
| Gross Profit (TTM) | 9.45M | |||
| EBITDA (TTM) | 1.90M | |||
| EBIT (TTM) | -443.20K | |||
| Net Income (TTM) | 23.33M | |||
| Net Income Avl. to Common (TTM) | 23.33M | |||
| Total Revenue Growth (Q YOY) | 142.82% | |||
| Earnings Growth (Q YOY) | -75.33% | |||
| EPS Diluted (TTM) | 1.86 | |||
| EPS Diluted Growth (Q YOY) | 280.39% | |||
| Balance Sheet | HGHAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.04M | |||
| Cash Per Share (Q) | $0.24 | |||
| Total Current Assets (Q) | 6.20M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 17.09M | |||
| Current Ratio (Q) | 2.433 | |||
| Book Value Per Share (Q) | $1.37 | |||
| Total Assets (Q) | 24.41M | |||
| Total Current Liabilities (Q) | 2.55M | |||
| Total Debt (Q) | 3.54M | |||
| Total Liabilities (Q) | 7.32M | |||
| Total Common Equity (Q) | 17.09M | |||
| Cash Flow | HGHAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -19.96M | |||
| Cash from Financing (TTM) | -27.87M | |||
| Net Change in Cash (TTM) | -31.25M | |||
| Levered Free Cash Flow (TTM) | 13.27M | |||
| Cash from Operations (TTM) | 16.27M | |||
